Introduction: All epidemiological studies suggest that vitamin D deficiency is prevalent
among the Polish general population. Since vitamin D deficiency was shown to be among …

The large global burden of respiratory syncytial virus (RSV) respiratory tract infections in
young children and older adults has gained increased recognition in recent years. Recent …

Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

The monoclonal antibody nirsevimab was at least 70% effective in preventing
hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory …

A monoclonal antibody for universal respiratory syncytial virus prophylaxis in infants has
recently been licensed. We share our experiences of integrating nirsevimab into the regional …

Background No overall estimate of respiratory syncytial virus (RSV)-associated
hospitalizations in children aged under 5 years has been published for the European Union …

Importance Respiratory syncytial virus (RSV) is a leading cause of pediatric hospitalizations.
Objective To describe the epidemiology and burden of RSV-associated hospitalizations …

Summary Background Galicia (Spain) was one of the first regions worldwide to incorporate
nirsevimab for universal respiratory syncytial virus (RSV) prophylaxis in infants into its …

Background Respiratory syncytial virus (RSV) infections cause an estimated 22-50 million
episodes of acute lower respiratory infections (ALRI) every year in children younger than 5 …

Background Respiratory syncytial virus (RSV) causes a considerable disease burden in
young children globally, but reliable estimates of RSV-related costs and health-related …